Brokered sales reported for MetLife (NYSE: MET) — Form 144 notices filed

Rhea-AI Filing Summary

MetLife (MET) reported Form 144 notices for sales of Common Stock. The excerpt lists individual dispositions dated 01/09/2026 (562 shares) and 03/02/2026 (725 shares). The filings identify brokers and plan/ account names associated with the transactions.

Insights

Securities Compliance Counsel

Routine Form 144 disclosures of brokered sales by holders, not a company issuance.

Form 144 entries show specific broker and account details with dated dispositions: 01/09/2026 (562 shares) and 03/02/2026 (725 shares). These are sale notices required under Section 144 when restricted or control securities are sold through a broker.

Timing and cash proceeds are not provided here; subsequent brokerage confirmations or Form 4/5 filings could supply final transfer or beneficial‑ownership changes. Regulatory compliance appears procedural based on the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays 745 Seventh Ave New York NY 10019	145	9948.45	652053867	03/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/17/2019	Purchase	BANK OF AMERICA			145	12/19/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	01/09/2026	562	44628.42
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	03/02/2026	725	53099

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MetLife (MET) Form 144 filing mean?

A Form 144 notice signals an intended sale of restricted or control securities. The excerpt lists brokered dispositions dated 01/09/2026 and 03/02/2026 with 562 and 725 shares respectively, showing compliance with resale reporting requirements.

How many MetLife (MET) shares are shown as sold in the excerpt?

The excerpt lists two specific dispositions: 562 shares on 01/09/2026 and 725 shares on 03/02/2026. These are individual reported transactions; aggregate totals are not provided in this excerpt.

Do Form 144 filings by MetLife insiders affect outstanding shares?

Form 144 itself reports intended resale of restricted or control stock and does not alter the company’s outstanding share count. The excerpt does not provide post‑sale ownership or outstanding shares data to assess any change.

Where can I find confirmation that the MetLife (MET) sales settled?

Settlement confirmation typically appears in broker records, Form 4/Form 5 amendments, or later SEC filings. The provided excerpt contains sale notices only and does not include settlement or cash‑proceeds confirmations.